Bibliothek

feed icon rss

Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
  • 1
    Digitale Medien
    Digitale Medien
    Amsterdam : Elsevier
    Biochemical and Biophysical Research Communications 180 (1991), S. 374-379 
    ISSN: 0006-291X
    Schlagwort(e): 2-Nal; 3-(2-naphthyl)alanine ; 3-Pal; 3-(3-pyridyl)alanine ; 3-Qal; 3-(3-quinolyl)alanine ; ILys; N-isopropyllysine ; NicLys; N-nicotinoyllysine ; PicLys; N-picolinoyllysine ; PzLys; N-pyrazinylcarbonyllysine ; c-PzACAla; cis-3-(4-pyrazinylcarbonylaminocyclohexyl)alanine ; pClPhe; 3-(4-chlorophenyl)alanine
    Quelle: Elsevier Journal Backfiles on ScienceDirect 1907 - 2002
    Thema: Biologie , Chemie und Pharmazie , Physik
    Materialart: Digitale Medien
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 2
    Digitale Medien
    Digitale Medien
    Amsterdam : Elsevier
    Biochemical and Biophysical Research Communications 180 (1991), S. 374-379 
    ISSN: 0006-291X
    Schlagwort(e): 2-Nal; 3-(2-naphthyl)alanine ; 3-Pal; 3-(3-pyridyl)alanine ; 3-Qal; 3-(3-quinolyl)alanine ; ILys; N-isopropyllysine ; NicLys; N-nicotinoyllysine ; PicLys; N-picolinoyllysine ; PzLys; N-pyrazinylcarbonyllysine ; c-PzACAla; cis-3-(4-pyrazinylcarbonylaminocyclohexyl)alanine ; pClPhe; 3-(4-chlorophenyl)alanine
    Quelle: Elsevier Journal Backfiles on ScienceDirect 1907 - 2002
    Thema: Biologie , Chemie und Pharmazie , Physik
    Materialart: Digitale Medien
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 3
    Digitale Medien
    Digitale Medien
    Springer
    Journal of molecular medicine 66 (1988), S. 583-590 
    ISSN: 1432-1440
    Schlagwort(e): Coenzyme Q10 ; Cardiomyopathy ; Bioenergetics ; Ejection fraction ; Cardiac output
    Quelle: Springer Online Journal Archives 1860-2000
    Thema: Medizin
    Notizen: Summary Coenzyme Q10 (CoQ10) is indispensable in mitochondrial bioenergetics and for human life to exist. 88/115 patients completed a trial of therapy with CoQ10 for cardiomyopathy. Patients were selected on the basis of clinical criteria,X-rays, electrocardiograms, echocardiography, and coronary angiography. Responses were monitored by ejection fractions, cardiac output, and improvements in functional classifications (NYHA). Of the 88 patients 75%–85% showed statistically significant increases in two monitored cardiac parameters. Patients with the lowest ejection fractions (approx. 10%–30%) showed the highest increases (115Δ%–210Δ%) and those with higher ejection fractions (50%–80%) showed increases of approx. 10Δ%–25Δ% on therapy. By functional classification, 17/21 in class IV, 52/62 in class III, and 4/5 in class II improved to lower classes. Clinical responses appeared over variable times, and are presumably based on mechanisms of DNA-RNA-protein synthesis of apoenzymes which restore levels of CoQ10 enzymes in a deficiency state. 10/21 (48%) of patients in class IV, 26/62 (42%) in class III, and 2/5 (40%) in class II had exceptionally low control blood levels of CoQ10. Clinical responses on therapy with CoQ10 appear maximal with blood levels of approx. 2.5 µg CoQ10/ml and higher during therapy.
    Materialart: Digitale Medien
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 4
    Digitale Medien
    Digitale Medien
    Springer
    Journal of molecular medicine 71 (1993), S. S140 
    ISSN: 1432-1440
    Schlagwort(e): Diastolic dysfunction ; Coenzyme Q10 ; Hypertension ; Mitral valve prolapse ; Fatigue
    Quelle: Springer Online Journal Archives 1860-2000
    Thema: Medizin
    Notizen: Summary Symptoms of fatigue and activity impairment, atypical precordial pain, and cardiac arrhythmia frequently precede by years the development of congestive heart failure. Of 115 patients with these symptoms, 60 were diagnosed as having hypertensive cardiovascular disease, 27 mitral valve prolapse syndrome, and 28 chronic fatigue syndrome. These symptoms are common with diastolic dysfunction, and diastolic function is energy dependent. All patients had blood pressure, clinical status, coenzyme Q10 (CoQ10) blood levels and echocardiographic measurement of diastolic function, systolic function, and myocardial thickness recorded before and after CoQ10 replacement. At control, 63 patients were functional class III and 54 class II; all showed diastolic dysfunction; the mean CoQ10 blood level was 0.855 μNg/ml; 65%,15%, and 7% showed significant myocardial hypertrophy, and 87%, 30%, and 11% had elevated blood pressure readings in hypertensive disease, mitral valve prolapse and chronic fatigue syndrome respectively. Except for higher blood pressure levels and more myocardial thickening in the hypertensive patients, there was little difference between the three groups. CoQ10 administration resulted in improvement in all; reduction in high blood pressure in 80%, and improvement in diastolic function in all patients with follow-up echocardiograms to date; a reduction in myocardial thickness in 53% of hypertensives and 36% of the combined prolapse and fatigue syndrome groups; and a reduced fractional shortening in those high at control and an increase in those initially low. Isolated diastolic dysfunction associated with moderately low CoQ10 blood levels is an extremely frequent finding in patients with three varied clinical entities sharing similar symptoms and CoQ10 replacement results in clinical improvement, lowering of elevated blood pressures, improved diastolic function, a decrease in myocardial thickness, and a normalization of systolic function.
    Materialart: Digitale Medien
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie hier...